BRAINCHIP HOLDINGS LIMITED (BRN)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

BRN - BRAINCHIP HOLDINGS LIMITED

FNArena Sector : Medical Equipment & Devices
Year End: June
GICS Industry Group : Software & Services
Debt/EBITDA: N/A
Index: ASX300 | ALL-ORDS | ALL-TECH

Brainchip Holdings is a holding company for its subsidiaries which provide neural computing technology and artificial neural networks through digital hardware and software. It operates in Australia and the US and has been a listed company since 2011.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.30

23 Dec
2024

0.050

OPEN

$0.25

20.00%

HIGH

$0.30

28,656,865

LOW

$0.25

OTHER COMPANIES IN THE SAME SECTOR
4DX . AT1 . AYA . BB1 . CAT . CBL . CGS . CMP . COH . CSX . CU6 . CVB . CYC . EBR . EMV . EYE . FPH . IDX . IME . IMR . IPD . LDX . MX1 . NAN . ONE . PCK . PEB . PGC . PME . RMD . SOM . TRJ . UBI . VTI .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx-2.4
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx0.3 M
Book Value Per Share xxxxxxxxxxxxxxx1.4
Net Operating Cash Flow xxxxxxxxxxxxxxx-26.4 M
Net Profit Margin xxxxxxxxxxxxxxx-12,448.51 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx-145.90 %
Return on Invested Capital xxxxxxxxxxxxxxx-136.24 %
Return on Assets xxxxxxxxxxxxxxx-119.86 %
Return on Equity xxxxxxxxxxxxxxx-145.90 %
Return on Total Capital xxxxxxxxxxxxxxx-128.51 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-26.6 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx2 M
Total Debt xxxxxxxxxxxxxxx2 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx21 M
Price To Book Value xxxxxxxxxxxxxxx12.36

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx0.2 M
Capex % of Sales xxxxxxxxxxxxxxx57.16 %
Cost of Goods Sold xxxxxxxxxxxxxxx1 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx41 M
Research & Development xxxxxxxxxxxxxxx9 M
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

BRN STOCK CHART